Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188079 | SCV000241683 | benign | not specified | 2016-06-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000364648 | SCV000416690 | uncertain significance | Intellectual Disability, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000474532 | SCV000557174 | benign | Intellectual disability, autosomal dominant 1 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000188079 | SCV000595701 | likely benign | not specified | 2017-02-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314731 | SCV000849017 | benign | Inborn genetic diseases | 2017-02-10 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003884382 | SCV004701622 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | MBD5: BS1, BS2 |
Prevention |
RCV003927742 | SCV004746594 | benign | MBD5-related disorder | 2019-06-13 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |